← Back to all trials
Not Yet Recruiting
NCT05691972
Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
Conditions: Temporal Hollowing
Sex: All
Ages: 22 Years – N/A
Phase: NA
Enrollment: 225
Sponsor: Galderma R&D
Location: United States
Summary
This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.
Eligibility Criteria
Inclusion Criteria:Males or non-pregnant, non-breastfeeding females, 22 years of age or olderIntent to undergo treatment for correction of temple hollowingExclusion Criteria:Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteinsKnown/previous allergy or hypersensitivity to local anesthetics, e.g., lidocaine or other amide-type anesthetics or nerve blocking agents (if intended to be used for that subject)Previous facial surgery (e.g., facelift) above the level of the horizontal line from subnasale that in the Treating Investigator´s opinion could interfere with the study safety and/or effectiveness assessmentsAny previous aesthetic procedures or implantsRecurrent temporal headaches such as temporal tendinitis migraine.
Have a history of migraines or frequent headaches, as determined by the (Treating) Investigator, that could interfere with the study safety and/or effectiveness assessments
Source: ClinicalTrials.gov (NCT05691972). StuddyBuddy aggregates publicly available trial information.